CCM device plus medications for heart failure with low pump strength
Part of Heart & circulation clinical trials.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with heart failure that causes symptoms (like shortness of breath or fatigue).
- Your ejection fraction (heart's pumping ability) is 40% or less.
- If you have a special pacemaker (CRT device), it must have been in place for more than 1 year and you still have significant symptoms.
- You do not have severe kidney disease (eGFR below 15) and are not on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This registry study follows patients who have or will get a CCM device to see how well it works and how safe it is over time. It helps doctors learn more about improving heart function in people with heart failure.
This study tests whether a heart-related device called CCM can improve symptoms and daily function in people with heart failure and a moderately reduced pumping strength. It may help if you’ve had recent heart-failure-related hospital care or urgent treatment and your heart and overall health fit the study limits.
This study tests a new heart scan method to help doctors improve pacemaker treatment for people with heart failure. If you already qualify for a special pacemaker called CRT, this scan may make the treatment work better for you.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This trial tests a heart device (CRT) that coordinates your heart's contractions, combined with a new electrical mapping technique to place leads more precisely. It's designed for people with weak heart function and abnormal electrical patterns who haven't improved enough with medications alone.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.